Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

OPTH

Optimi Health Corp

May 26 • 11:24AM ET

5.37

-0.48 -8.21 %

Healthcare • Drug Manufacturers - Specialty & Generic • Canada • Small • NASD

Today, 7:05 AMOptimi Health completes 6% psilocybin extract batch for Australian treatment-resistant depression and European clinical research programs

Held by: PSIL

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.93	Insider Own	22.73%	Shs Outstand	3.22M	Perf Week	-24.62%
Market Cap	519.71M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	1.95M	Perf Month	-32.31%
Enterprise Value	524.12M	PEG	-	EPS next Q	-	Inst Own	0.05%	Short Float	-	Perf Quarter	-23.70%
Income	-2.96M	P/S	1332.59	EPS this Y	-	Inst Trans	-	Short Ratio	-	Perf Half Y	-31.35%
Sales	0.39M	P/B	4.73	EPS next Y	-	ROA	-27.66%	Short Interest	-	Perf YTD	-21.63%
Book/sh	1.14	P/C	1443.63	EPS next 5Y	-	ROE	-43.87%	52W High	8.84 -39.24%	Perf Year	15.48%
Cash/sh	0.00	P/FCF	-	EPS past 3/5Y	27.91% -72.14%	ROIC	-78.40%	52W Low	3.00 79.00%	Perf 3Y	5.29%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	68.99% -	Gross Margin	-324.40%	Volatility	14.96% 11.57%	Perf 5Y	-71.24%
Dividend TTM	-	EV/Sales	1343.89	EPS Y/Y TTM	-1866.03%	Oper. Margin	-824.18%	ATR (14)	0.76	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.09	Sales Y/Y TTM	61.11%	Profit Margin	-751.47%	RSI (14)	32.04	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	0.12	EPS Q/Q	13.56%	SMA20	-22.59%	Beta	1.27	Target Price	-
Payout	-	Debt/Eq	1.30	Sales Q/Q	-100.00%	SMA50	-21.12%	Rel Volume	1.43	Prev Close	5.85
Employees	-	LT Debt/Eq	0.03	Earnings	-	SMA200	-16.95%	Avg Volume	55.21K	Price	5.37
IPO	May 20, 2026	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	25,829	Change	-8.21%

Today 07:00AM	Optimi Health Advances Highest-Purity Natural Psilocybin Extract to Date (Newsfile Corp.) -8.21%
May-21-26 01:42PM	SRx Health Decided To Invest In A Psychedelic Drug Company That Just Went Public Heres What Aided The Decision (Stocktwits) -6.25%
01:07PM	Optimi Health Announces Closing of Oversubscribed US$15 Million Public Offering (Newsfile Corp.)
May-20-26 11:30AM	Optimi Health Announces Pricing of Oversubscribed US$15 Million Public Offering and Nasdaq Uplisting (PR Newswire) -13.83%
08:00AM	Optimi Health gibt Preisfestsetzung fur uberzeichnetes offentliches Angebot in Hohe von 15 Mio. US-$ und Nasdaq-Uplisting bekannt (Newsfile)

Optimi Health Corp. functions as an end-to-end GMP manufacturer and supplier of psychedelic substances. It offers formulation, active pharmaceutical ingredients (APIs), and drug product manufacturing from preclinical stages to analysis and commercial distribution and It also offers botanical psilocybin and MDMA. The company was founded on May 27, 2020 and is headquartered in Squamish, Canada.

Co-Founder & ChairmanMr. John James Wilson

Co-FounderMr. Dane Stevens

Co-FounderMr. Bryan Edward Safarik

Co-FounderMr. Jacob Safarik

Chief Science OfficerDr. Preston A. Chase

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

OPTH

Optimi Health Corp

Upgrade your Finviz experience